TrialInternational journal of chronic obstructive pulmonary disease2017

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.

Cheong-Ju Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.